FDA Adverse Event Malfunction Summary report: N

COBAS 6000 CORE

MDR report key: 2061430 · Received April 18, 2011

Report

Report Number
1823260-2011-02095
Event Type
Malfunction
Date Received
April 18, 2011
Date of Event
March 29, 2011
Report Date
June 24, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LCP
PMA / PMN Number
K060373
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ME, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION CONFIRMED THERE WAS A SOFTWARE ERROR IN THE CANCELLATION PROCESS FOR THE (B)(6) MEASUREMENT. THIS ISSUE HAD ALREADY BEEN RESOLVED BY A MANDATORY SOFTWARE UPDATE. FOLLOW UP WITH THE USER CONFIRMED THEY HAD NOT EXPERIENCED FURTHER ISSUES SINCE THE SOFTWARE ON THEIR ANALYZER WAS UPDATED.

Description of Event or Problem · 1

THE USER RECEIVED QUESTIONABLE HEMOGLOBIN A1C GENERATION 2 (HGA1C) RESULTS FOR THREE PATIENT SAMPLES OF WHICH THE RESULTS FOR TWO WERE DISCREPANT. PATIENT SAMPLE 1 GAVE NO RESULT AND A DATA FLAG ON THE INITIAL TESTING. THE AUTOMATIC REPEAT RESULT WAS 9.9%. AFTER REPLACING THE REAGENT CASSETTE AND RETESTING, THE RESULT WAS 7.7%. PATIENT SAMPLE 2 GAVE NO RESULT AND A DATA FLAG ON THE INITIAL TESTING. THE AUTOMATIC REPEAT RESULT WAS 9.1%. AFTER REPLACING THE REAGENT CASSETTE AND RETESTING, THE RESULT WAS 7.1%. THE AUTOMATIC REPEAT RESULT WAS REPORTED OUTSIDE THE LABORATORY. IT WAS UNKNOWN IF THE PATIENTS WERE ADVERSELY AFFECTED. THE HGA1C REAGENT LOT NUMBER WAS 64073701. THE FIELD SERVICE REPRESENTATIVE SUSPECTED THERE WAS A PROBLEM WITH THE REAGENT PACK. THE USER STATED ALL HGA1C RESULTS WERE ACCEPTABLE AFTER REPLACING THE REAGENT PACK. THE FIELD SERVICE REPRESENTATIVE CHECKED MULTIPLE AREAS OF THE ANALYZER AND THE USER VERIFIED THE ANALYZER BY RUNNING CALIBRATION AND QUALITY CONTROL WITH ALL RESULTS WITHIN SPECIFICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COBAS 6000 CORE CLINICAL CHEMISTRY ANALYZER LCP ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1